Company: LENZ
Filing Date: 2025-06-10
Form Type: 8-K
Source: 0001815776-25-000036
Chunk: 0

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-06-10
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

LENZ Therapeutics, Inc. (the “ Company”) held its 2025 annual meeting of stockholders on June 10, 2025 (the “ Annual Meeting”). Of the 27,544,520 shares of the Company’s common stock outstanding as of the record date of April 14, 2025, 17,983,676 shares were represented at the Annual Meeting, either by proxy or by attending the meeting. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

1. Election of Class III and Class I Directors. The following nominees were elected to serve as Class III directors to hold office until the Company's 2027 annual meeting of stockholders and Class I directors to hold office until the Company’s 2028 annual meeting of stockholders, or until their respective successor has been duly elected and qualified:

  Nominee                   Class       Votes For      Votes Withheld      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────────────────────
  Kimberlee C. Drapkin      III        12,390,015           3,157,989             2,435,672  
  Zach Scheiner             III        12,714,299           2,833,705             2,435,672  
  Frederic Guerard          I          15,369,962             178,042             2,435,672  
  James McCollum            I          15,397,013             150,991             2,435,672  

2. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified based on the following results of voting:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  17,979,770              2,698            1,208      —                 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  LENZ THERAPEUTICS, INC.                                                                
  Dated: June 10,